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SUPPLEMENTAL MATERIAL
Table S1. Methods and interassay coefficients (CV) of variation for biomarkers assessed 
from blood samples at age 60-64 years. 
 *Any results that fell below the lower detection limit of the assay were assigned a notional 
value, obtained by dividing the lower detection limit by the square root of 2.  
 
 
Cardiovascular disease 
biomarker 
Units Assay/Method CV (%) 
    
E-selectin ng/ml High sensitivity ELISA <10.0% 
C-reactive protein 
(CRP) 
mg/l 
Particle-enhanced 
immunoturbidimetric assay 
4.3% at 3.4 mg/L 
1.8% at 11.9 mg/L 
Interleukin-6 (IL6) pg/ml 
Enzyme-linked immunosorbent assay 
(ELISA) 
6.5% 
Tissue plasminogen 
activator (tPA) 
ng/ml ELISA 6.6% 
Leptin ng/ml 
In-house radioimmunoassay validated 
against commercially available assays 
<10.0% 
Adiponectin μg/ml ELISA <7.5% 
 
 
Table S2. Mean percentage difference (95% confidence intervals) in biomarkers per standard deviation increases in time spent 
sedentary (SED), in light (LPA) and moderate-to-vigorous intensity physical activity (MVPA), and overall physical activity energy 
expenditure (PAEE) at age 60-64: after exclusion of participants with doctor-diagnosed cardiovascular disease. 
 Men   Women 
 Model 1  Model 2  Model 3  Model 1  Model 2  Model 3 
            
CRP (♂=684; ♀=756)         
SED 7.2 (0.5, 13.9)  4.7 (-1.9, 11.3)  5.4 (-1.2, 12.0)  17.2 (11.0, 23.4)  15.6 (9.2, 22.0)  8.8 (24.2, 15.1) 
LPA -4.8 (-11.6, 1.9)  -4.6 (-11.3, 2.1)  -4.0 (-10.5, 2.6)  -14.2 (-20.5, -8.0)  -13.1 (-19.5, -6.6)  -6.8 (-13.1, -0.5) 
MVPA -8.7 (-15.2, -2.2)  -6.1 (-12.6, 0.4)  -3.8 (-10.3, 2.7)  -17.9 (-23.9, -11.8)  -14.7 (-20.8, -8.5)  -9.2 (-15.2, -3.2) 
PAEE -9.6 (-16.2, -3.1)  -7.7 (-14.3, -1.1)  -5.5 (-12.1, 1.1)  -19.9 (-26.1, -13.7)  -17.5 (-23.9, -11.1)  -10.5 (-16.9, -4.1) 
IL-6 (♂=678; ♀=751)         
SED 7.7 (2.4, 13.1)  6.0 (0.7, 11.4)  5.0 (-0.03, 10.3)  16.3 (11.2, 21.4)  14.3 (9.0, 19.5)  10.1 (4.8, 15.4) 
LPA -4.4 (-9.7, 1.0)  -3.5 (-8.9, 1.8)  -3.1 (-8.3, 2.2)  -13.7 (-18.8, -8.9)  -12.1 (-17.3, -6.8)  -8.2 (-13.5, -2.9) 
 
 
MVPA -11.0 (-16.1, -5.9)  -8.2 (-13.3, -3.1)  -6.6 (-11.7, -1.5)  -16.2 (-21.1, -11.3)  -13.1 (-18.1, -8.1)  -9.6 (-14.6, -4.6) 
PAEE -11.1 (-16.3, -6.0)  -8.9 (-14.1, -3.6)  -7.3 (-12.5, -2.1)  -18.1 (-23.2, -13.1)  -15.6 (-20.8, -10.3)  -11.3 (-16.6, -5.9) 
t-PA (♂=623; ♀=681)         
SED 11.2 (6.2, 16.1)  9.9 (4.8, 15.0)  8.5 (3.6, 13.5)  11.7 (7.0, 16.5)  10.8 (5.7, 15.8)  6.2 (1.2, 11.3) 
LPA -10.9 (-15.8, -5.9)  -10.1 (15.1, -5.0)  -9.2 (-14.1, -4.4)  -10.2 (-15.0, -5.4)  -9.0 (-14.0, -3.9)  -5.0 (-10.0, -0.04) 
MVPA -6.1 (-10.9, -1.3)  -4.1 (-9.0, 0.8)  -2.1 (-6.9, 2.7)  -10.3 (-14.9, -5.8)  -9.9 (-14.7, -5.2)  -5.9 (-10.6, -1.2) 
PAEE -10.3 (-15.1, -5.4)  -8.6 (-13.6, -3.6)  -6.6 (-11.5, -1.6)  -12.1 (-16.8, -7.4)  -11.5 (-16.5, -6.5)  -6.7 (-11.7, -1.6) 
E-selectin (♂=678; ♀=752)         
SED 1.7 (-1.6, 5.0)  0.9 (-2.4, 4.2)  0.2 (-3.1, 3.5)  2.4 (-0.8,5.6)  2.5 (-0.9, 5.9)  0.5 (-3.0, 4.0) 
LPA -1.3 (-4.6, 2.0)  -1.0 (-4.3, 2.3)  -0.6 (-3.9, 2.6)  -1.8 (-5.1, 1.4)  -1.8 (-5.2, 1.6)  -0.09 (-3.5, 3.4) 
MVPA -1.8 (-5., 1.4)  -0.2 (-3.5, 3.0)  0.9 (-2.3, 4.1)  -3.0 (-6.1, 0.2)  -3.0 (-6.2, 0.2)  -1.5 (-4.8, 1.8) 
PAEE -2.2 (-5.4, 1.0)  -0.8 (-4.1, 2.5)  0.3 (-2.9, 3.6)  -2.8 (-6.0, 0.4)  -2.9 (-6.3, 0.5)  -0.9 *-4.4, 2.6) 
Leptin (♂=680; ♀=753)         
SED 10.8 (5.2, 16.3)  7.6 (2.1, 13.0)  3.4 (-0.7, 7.6)  23.2 (17.8, 28.7))  18.8 (13.2, 24.3)  5.3 (1.0, 9.6) 
LPA -5.8 (-11.4, -0.2)  -3.3 (-8.7, 2.1)  -1.2 (-5.3, 2.9)  -19.8 (-25.3, -14.3)  -15.7 (-21.3, -10.1)  -3.7 (-7.9, 0.6) 
MVPA -16.0 (-21.3, -10.7)  -12.8 (-17.9, -7.6)  -6.5 (-10.4, -2.5)  -22.4 (-27.7, -17.1)  -17.8 (-23.0, -12.5)  -6.9 (-10.9, -3.0) 
 
 
Model 1: adjusted for age. Model 2: adjusted for age, SEP, smoking history, long-term illness, health problem or disability, blood pressure and 
medication use. Model 3: as for model 2 plus added adjustment for fat mass index. 
 
 
PAEE -16.3 (-21.7, -10.9)  -12.7 (-18.0, -7.4)  -6.3 (-10.3, -2.2)  -25.7 (-31.1, -20.3)  -20.7 (-26.2, -15.2)  -6.8 (-11.0, -25.0) 
Adiponectin (♂=680; ♀=752)     
SED -6.7 (-11.7, -1.8)  -4.9 -10.1, 0.3)  -4.0 (-9.1, 1.1)  -11.4 (-15.6, -7.2)  -8.7 (-13.1, -4.3)  -5.2 (-9.6, -0.8) 
LPA 6.0 (1.0, 11.0)  4.4 (-0.7, 9.6)  4.0 (-1.0, 9.1)  -11.3 (7.0, 15.5)  8.9 (4.5, 13.2)  5.7 (1.4, 10.1) 
MVPA 5.0 (0.1, 9.8)  3. (-1.7, 8.2)  1.8 (-3.2, 6.7)  6.4 (2.3, 10.5)  3.6 (-0.6, 7.8)  0.6 (-3.6, 4.7) 
PAEE 6.8 (1.9, 11.7)  4.9 (-0.2, 9.9)  3.4 (-1.7, 8.4)  10.2 (6.0, 14.5)  7.3 (2.9, 11.6)  3.5 (-0.9, 7.9) 
